Logo
x

Search

Subscribe Now

Narcolepsy

Jazz' Sunosi (solriamfetol) Receives NICE Recommendation for the Treatment of Excessive Daytime Sleepiness Caused by Narcolepsy

Jazz' Sunosi (solriamfetol) Receives NICE Recommendation for the Treatment of Excessive Daytime Sleepiness Caused by Narcolepsy

  • November 19, 2021
Harmony Acquires ConSynance's Asset for the Treatment of Narcolepsy and other Rare Neurological Diseases

Harmony Acquires ConSynance's Asset for the Treatment of Narcolepsy and other Rare Neurological Diseases

  • August 10, 2021
Jazz Reports Results of Xywav (calcium- magnesium- potassium- and sodium oxybates) in P-III Study for Cataplexy or EDS in Patients with Narcolepsy

Jazz Reports Results of Xywav (calcium- magnesium- potassium- and sodium oxybates) in P-III Study for Cataplexy or EDS in Patients...

  • October 21, 2020
Jazz Pharmaceuticals' Xywav (calcium- magnesium- potassium- and sodium oxybates) Receives the US FDA's Approval for Cataplexy or Excessive Daytime Sleepiness Associated with Narcolepsy

Jazz Pharmaceuticals' Xywav (calcium- magnesium- potassium- and sodium oxybates) Receives the US FDA's Approval for Cataplexy or E...

  • July 22, 2020
Jazz Reports Results of JZP-258 in a P-III Study to Treat Cataplexy and Excessive Daytime Sleepiness in Patients with Narcolepsy

Jazz Reports Results of JZP-258 in a P-III Study to Treat Cataplexy and Excessive Daytime Sleepiness in Patients with Narcolepsy

  • September 26, 2019
Harmony Biosciences' Wakix (pitolisant) Receives the US FDA's Approval for Treatment of Excessive Daytime Sleepiness in Adult Patients with Narcolepsy

Harmony Biosciences' Wakix (pitolisant) Receives the US FDA's Approval for Treatment of Excessive Daytime Sleepiness in Adult Pati...

  • August 15, 2019
Image

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2024 PharmaShots - All Rights Reserved.